{"product_id":"fempro","title":"Fempro","description":"\u003ch3 data-start=\"286\" data-end=\"310\"\u003eWhat is Letrozole?\u003c\/h3\u003e\r\n\u003cp data-start=\"311\" data-end=\"662\"\u003e\u003cstrong data-start=\"311\" data-end=\"324\"\u003eLetrozole\u003c\/strong\u003e is an oral nonsteroidal aromatase inhibitor primarily used in the management of hormone receptor‑positive breast cancer in postmenopausal women. It works by inhibiting the aromatase enzyme responsible for converting androgens into estrogens, thereby significantly reducing estrogen levels that drive the growth of certain breast cancers.\u003c\/p\u003e\r\n\u003cp data-start=\"664\" data-end=\"751\"\u003e\u003cem data-start=\"664\" data-end=\"751\"\u003eReference: U.S. FDA Femara Prescribing Information; PubMed (Lønning \u0026amp; Eikesdal, 2011)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"753\" data-end=\"756\"\u003e\r\n\u003ch3 data-start=\"758\" data-end=\"822\"\u003eWhat are the other popular and common names for Letrozole?\u003c\/h3\u003e\r\n\u003cp data-start=\"823\" data-end=\"1017\"\u003eLetrozole is most commonly marketed under the brand name \u003cstrong data-start=\"880\" data-end=\"891\"\u003eFemara®\u003c\/strong\u003e. It is widely recognized in clinical practice and literature by both its generic name (letrozole) and its brand name, Femara.\u003c\/p\u003e\r\n\u003cp data-start=\"1019\" data-end=\"1053\"\u003e\u003cem data-start=\"1019\" data-end=\"1053\"\u003eReference: MedlinePlus; U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1055\" data-end=\"1058\"\u003e\r\n\u003ch3 data-start=\"1060\" data-end=\"1111\"\u003eWhat is the drug classification of Letrozole?\u003c\/h3\u003e\r\n\u003cp data-start=\"1112\" data-end=\"1300\"\u003eLetrozole is classified as an \u003cstrong data-start=\"1142\" data-end=\"1165\"\u003earomatase inhibitor\u003c\/strong\u003e. It belongs to the group of nonsteroidal aromatase inhibitors used in oncology for the treatment of estrogen‑dependent breast cancers.\u003c\/p\u003e\r\n\u003cp data-start=\"1302\" data-end=\"1376\"\u003e\u003cem data-start=\"1302\" data-end=\"1376\"\u003eReference: World Health Organization (WHO) Oncology Guidelines; U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1378\" data-end=\"1381\"\u003e\r\n\u003ch3 data-start=\"1383\" data-end=\"1429\"\u003eWhat is the mode of action of Letrozole?\u003c\/h3\u003e\r\n\u003cp data-start=\"1430\" data-end=\"1741\"\u003eLetrozole functions by competitively inhibiting the aromatase enzyme. This inhibition prevents the conversion of androgens (androstenedione and testosterone) into estrogen, leading to lower circulating estrogen levels. The reduced estrogen concentration limits the growth stimulus for estrogen‑dependent tumors.\u003c\/p\u003e\r\n\u003cp data-start=\"1743\" data-end=\"1799\"\u003e\u003cem data-start=\"1743\" data-end=\"1799\"\u003eReference: PubMed (Lønning \u0026amp; Eikesdal, 2011); U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1801\" data-end=\"1804\"\u003e\r\n\u003ch3 data-start=\"1806\" data-end=\"1851\"\u003eWhat are the primary uses of Letrozole?\u003c\/h3\u003e\r\n\u003cp data-start=\"1852\" data-end=\"1886\"\u003eLetrozole is primarily used for:\u003c\/p\u003e\r\n\u003cul data-start=\"1887\" data-end=\"2356\"\u003e\r\n\u003cli data-start=\"1887\" data-end=\"2066\"\u003e\n\u003cstrong data-start=\"1889\" data-end=\"1930\"\u003eAdvanced or Metastatic Breast Cancer:\u003c\/strong\u003e Treating hormone receptor‑positive breast cancer in postmenopausal women who have progressed on or are intolerant to other therapies.\u003c\/li\u003e\r\n\u003cli data-start=\"2067\" data-end=\"2198\"\u003e\n\u003cstrong data-start=\"2069\" data-end=\"2090\"\u003eAdjuvant Therapy:\u003c\/strong\u003e Reducing the risk of recurrence in early-stage hormone receptor‑positive breast cancer following surgery.\u003c\/li\u003e\r\n\u003cli data-start=\"2199\" data-end=\"2356\"\u003e\n\u003cstrong data-start=\"2201\" data-end=\"2220\"\u003eOff‑Label Uses:\u003c\/strong\u003e It is sometimes used off‑label for ovulation induction in women with polycystic ovary syndrome (PCOS) under strict medical supervision.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2358\" data-end=\"2441\"\u003e\u003cem data-start=\"2358\" data-end=\"2441\"\u003eReference: U.S. FDA; National Comprehensive Cancer Network (NCCN) Guidelines; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2443\" data-end=\"2446\"\u003e\r\n\u003ch3 data-start=\"2448\" data-end=\"2518\"\u003eWhat is the recommended dosage and administration for Letrozole?\u003c\/h3\u003e\r\n\u003cul data-start=\"2519\" data-end=\"2889\"\u003e\r\n\u003cli data-start=\"2519\" data-end=\"2611\"\u003e\n\u003cstrong data-start=\"2521\" data-end=\"2550\"\u003eDosage for Breast Cancer:\u003c\/strong\u003e The typical dosage is \u003cstrong data-start=\"2573\" data-end=\"2594\"\u003e2.5 mg once daily\u003c\/strong\u003e, taken orally.\u003c\/li\u003e\r\n\u003cli data-start=\"2612\" data-end=\"2767\"\u003e\n\u003cstrong data-start=\"2614\" data-end=\"2633\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"2638\" data-end=\"2767\"\u003e\r\n\u003cli data-start=\"2638\" data-end=\"2686\"\u003eLetrozole can be taken with or without food.\u003c\/li\u003e\r\n\u003cli data-start=\"2689\" data-end=\"2767\"\u003eIt should be taken at the same time each day to maintain steady drug levels.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"2768\" data-end=\"2889\"\u003e\n\u003cstrong data-start=\"2770\" data-end=\"2817\"\u003eDosage for Ovulation Induction (Off‑Label):\u003c\/strong\u003e The dosing regimen may differ and should be determined by a specialist.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2891\" data-end=\"2963\"\u003e\u003cem data-start=\"2891\" data-end=\"2963\"\u003eReference: U.S. FDA Femara Prescribing Information; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2965\" data-end=\"2968\"\u003e\r\n\u003ch3 data-start=\"2970\" data-end=\"3032\"\u003eWhat prescribing information is important for Letrozole?\u003c\/h3\u003e\r\n\u003cul data-start=\"3033\" data-end=\"3631\"\u003e\r\n\u003cli data-start=\"3033\" data-end=\"3222\"\u003e\n\u003cstrong data-start=\"3035\" data-end=\"3051\"\u003eIndications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3056\" data-end=\"3222\"\u003e\r\n\u003cli data-start=\"3056\" data-end=\"3222\"\u003eLetrozole is indicated for the treatment of hormone receptor‑positive advanced breast cancer and as adjuvant therapy in early breast cancer in postmenopausal women.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3223\" data-end=\"3353\"\u003e\n\u003cstrong data-start=\"3225\" data-end=\"3247\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3252\" data-end=\"3353\"\u003e\r\n\u003cli data-start=\"3252\" data-end=\"3353\"\u003eIt is contraindicated in premenopausal women and during pregnancy due to its teratogenic potential.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3354\" data-end=\"3495\"\u003e\n\u003cstrong data-start=\"3356\" data-end=\"3371\"\u003eMonitoring:\u003c\/strong\u003e\r\n\u003cul data-start=\"3376\" data-end=\"3495\"\u003e\r\n\u003cli data-start=\"3376\" data-end=\"3495\"\u003eRegular monitoring of liver function, lipid profiles, and bone mineral density (in long‑term therapy) is recommended.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3496\" data-end=\"3631\"\u003e\n\u003cstrong data-start=\"3498\" data-end=\"3525\"\u003eSpecial Considerations:\u003c\/strong\u003e\r\n\u003cul data-start=\"3530\" data-end=\"3631\"\u003e\r\n\u003cli data-start=\"3530\" data-end=\"3631\"\u003ePatients should undergo hormonal receptor testing to confirm estrogen dependence before initiation.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3633\" data-end=\"3707\"\u003e\u003cem data-start=\"3633\" data-end=\"3707\"\u003eReference: U.S. FDA Femara Prescribing Information; NCCN Guidelines; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3709\" data-end=\"3712\"\u003e\r\n\u003ch3 data-start=\"3714\" data-end=\"3812\"\u003eWhat safety information, side effects, warnings, and cautions are associated with Letrozole?\u003c\/h3\u003e\r\n\u003cul data-start=\"3813\" data-end=\"4648\"\u003e\r\n\u003cli data-start=\"3813\" data-end=\"3971\"\u003e\n\u003cstrong data-start=\"3815\" data-end=\"3839\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"3844\" data-end=\"3971\"\u003e\r\n\u003cli data-start=\"3844\" data-end=\"3893\"\u003eHot flashes, joint pain, fatigue, and nausea.\u003c\/li\u003e\r\n\u003cli data-start=\"3896\" data-end=\"3971\"\u003eIncreased cholesterol levels and risk of osteoporosis with long‑term use.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3972\" data-end=\"4163\"\u003e\n\u003cstrong data-start=\"3974\" data-end=\"3999\"\u003eSerious Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"4004\" data-end=\"4163\"\u003e\r\n\u003cli data-start=\"4004\" data-end=\"4075\"\u003eOsteoporosis and bone fractures, especially in long‑term treatment.\u003c\/li\u003e\r\n\u003cli data-start=\"4078\" data-end=\"4163\"\u003eHepatotoxicity, although rare, can occur; liver function tests should be monitored.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4164\" data-end=\"4526\"\u003e\n\u003cstrong data-start=\"4166\" data-end=\"4190\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4195\" data-end=\"4526\"\u003e\r\n\u003cli data-start=\"4195\" data-end=\"4324\"\u003e\n\u003cstrong data-start=\"4197\" data-end=\"4213\"\u003eBone Health:\u003c\/strong\u003e Long‑term use may lead to decreased bone mineral density. Supplemental calcium and vitamin D may be advised.\u003c\/li\u003e\r\n\u003cli data-start=\"4327\" data-end=\"4423\"\u003e\n\u003cstrong data-start=\"4329\" data-end=\"4353\"\u003eCardiovascular Risk:\u003c\/strong\u003e Monitor lipid levels as treatment may lead to hypercholesterolemia.\u003c\/li\u003e\r\n\u003cli data-start=\"4426\" data-end=\"4526\"\u003e\n\u003cstrong data-start=\"4428\" data-end=\"4442\"\u003ePregnancy:\u003c\/strong\u003e Letrozole is contraindicated in pregnancy and lactation due to teratogenic effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4527\" data-end=\"4648\"\u003e\n\u003cstrong data-start=\"4529\" data-end=\"4553\"\u003eAdditional Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4558\" data-end=\"4648\"\u003e\r\n\u003cli data-start=\"4558\" data-end=\"4645\"\u003eAvoid use in patients with a history of liver disease unless benefits outweigh risks.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4649\" data-end=\"4722\"\u003e\u003cem data-start=\"4649\" data-end=\"4722\"\u003eReference: U.S. FDA; PubMed (Lønning \u0026amp; Eikesdal, 2011); NCCN Guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4724\" data-end=\"4727\"\u003e\r\n\u003ch3 data-start=\"4729\" data-end=\"4794\"\u003eWhat drug interactions should be considered with Letrozole?\u003c\/h3\u003e\r\n\u003cul data-start=\"4795\" data-end=\"5283\"\u003e\r\n\u003cli data-start=\"4795\" data-end=\"4996\"\u003e\n\u003cstrong data-start=\"4797\" data-end=\"4821\"\u003eCYP450 Interactions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4826\" data-end=\"4996\"\u003e\r\n\u003cli data-start=\"4826\" data-end=\"4996\"\u003eLetrozole is metabolized by the liver, primarily via CYP3A4. Strong inhibitors (e.g., ketoconazole) or inducers (e.g., rifampin) of CYP3A4 may affect its plasma levels.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4997\" data-end=\"5133\"\u003e\n\u003cstrong data-start=\"4999\" data-end=\"5025\"\u003eOther Hormonal Agents:\u003c\/strong\u003e\r\n\u003cul data-start=\"5030\" data-end=\"5133\"\u003e\r\n\u003cli data-start=\"5030\" data-end=\"5133\"\u003eConcomitant use with other hormone therapies should be carefully monitored to avoid additive effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5134\" data-end=\"5283\"\u003e\n\u003cstrong data-start=\"5136\" data-end=\"5164\"\u003eBone Health Medications:\u003c\/strong\u003e\r\n\u003cul data-start=\"5169\" data-end=\"5283\"\u003e\r\n\u003cli data-start=\"5169\" data-end=\"5280\"\u003eWhen used with medications that affect bone metabolism (e.g., corticosteroids), monitor bone density closely.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5284\" data-end=\"5346\"\u003e\u003cem data-start=\"5284\" data-end=\"5346\"\u003eReference: U.S. FDA; Clinical Pharmacology Reviews on PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5348\" data-end=\"5351\"\u003e\r\n\u003ch3 data-start=\"5353\" data-end=\"5390\"\u003eFrequently Asked Questions (FAQs)\u003c\/h3\u003e\r\n\u003cp data-start=\"5392\" data-end=\"5652\"\u003e\u003cstrong data-start=\"5392\" data-end=\"5446\"\u003eQ: How does Letrozole work to treat breast cancer?\u003c\/strong\u003e\u003cbr data-start=\"5446\" data-end=\"5449\"\u003eA: Letrozole inhibits the aromatase enzyme, reducing estrogen production. Lower estrogen levels decrease the growth stimulus for estrogen‑dependent breast cancer cells, thereby slowing tumor progression.\u003c\/p\u003e\r\n\u003cp data-start=\"5654\" data-end=\"5901\"\u003e\u003cstrong data-start=\"5654\" data-end=\"5702\"\u003eQ: Is Letrozole used only for breast cancer?\u003c\/strong\u003e\u003cbr data-start=\"5702\" data-end=\"5705\"\u003eA: Primarily, yes. Letrozole is approved for advanced and early hormone receptor‑positive breast cancer in postmenopausal women. It is also used off‑label for ovulation induction in certain cases.\u003c\/p\u003e\r\n\u003cp data-start=\"5903\" data-end=\"6154\"\u003e\u003cstrong data-start=\"5903\" data-end=\"5965\"\u003eQ: How soon will I see an effect after starting Letrozole?\u003c\/strong\u003e\u003cbr data-start=\"5965\" data-end=\"5968\"\u003eA: Some patients may notice a reduction in symptoms such as hot flashes within a few weeks, but the full therapeutic effect on tumor progression is usually evaluated over several months.\u003c\/p\u003e\r\n\u003cp data-start=\"6156\" data-end=\"6402\"\u003e\u003cstrong data-start=\"6156\" data-end=\"6218\"\u003eQ: What precautions should be taken regarding bone health?\u003c\/strong\u003e\u003cbr data-start=\"6218\" data-end=\"6221\"\u003eA: Long‑term therapy with letrozole can decrease bone mineral density. Patients may be advised to take calcium and vitamin D supplements and undergo regular bone density monitoring.\u003c\/p\u003e\r\n\u003cp data-start=\"6404\" data-end=\"6547\"\u003e\u003cstrong data-start=\"6404\" data-end=\"6450\"\u003eQ: Can Letrozole be used during pregnancy?\u003c\/strong\u003e\u003cbr data-start=\"6450\" data-end=\"6453\"\u003eA: No, letrozole is contraindicated during pregnancy due to its potential to cause fetal harm.\u003c\/p\u003e\r\n\u003cp data-start=\"6549\" data-end=\"6765\"\u003e\u003cstrong data-start=\"6549\" data-end=\"6590\"\u003eQ: What should I do if I miss a dose?\u003c\/strong\u003e\u003cbr data-start=\"6590\" data-end=\"6593\"\u003eA: If you miss a dose, take it as soon as you remember. Do not double the dose to catch up. Consistency is key; consult your healthcare provider for any dosing adjustments.\u003c\/p\u003e\r\n\u003cp data-start=\"6767\" data-end=\"6844\"\u003e\u003cem data-start=\"6767\" data-end=\"6844\"\u003eReference: U.S. FDA Femara Prescribing Information; NCCN Guidelines; PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"6846\" data-end=\"6849\"\u003e\r\n\u003ch3 data-start=\"6851\" data-end=\"6944\"\u003eWhere can I find additional clinical evidence and detailed information about Letrozole?\u003c\/h3\u003e\r\n\u003cp data-start=\"6945\" data-end=\"7046\"\u003eFor further details on clinical studies, dosing guidelines, and safety monitoring, please refer to:\u003c\/p\u003e\r\n\u003cul data-start=\"7047\" data-end=\"7516\"\u003e\r\n\u003cli data-start=\"7047\" data-end=\"7135\"\u003e\n\u003cstrong data-start=\"7049\" data-end=\"7101\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"7102\" data-end=\"7133\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"7136\" data-end=\"7212\"\u003e\n\u003cstrong data-start=\"7138\" data-end=\"7161\"\u003eClinicalTrials.gov:\u003c\/strong\u003e Search for letrozole studies (e.g., NCT00003250)\u003c\/li\u003e\r\n\u003cli data-start=\"7213\" data-end=\"7327\"\u003e\n\u003cstrong data-start=\"7215\" data-end=\"7226\"\u003ePubMed:\u003c\/strong\u003e For peer‑reviewed research articles on letrozole in breast cancer (e.g., Lønning \u0026amp; Eikesdal, 2011)\u003c\/li\u003e\r\n\u003cli data-start=\"7328\" data-end=\"7415\"\u003e\n\u003cstrong data-start=\"7330\" data-end=\"7377\"\u003eWorld Health Organization (WHO) Guidelines:\u003c\/strong\u003e On hormone therapy in breast cancer\u003c\/li\u003e\r\n\u003cli data-start=\"7416\" data-end=\"7516\"\u003e\n\u003cstrong data-start=\"7418\" data-end=\"7478\"\u003eNational Comprehensive Cancer Network (NCCN) Guidelines:\u003c\/strong\u003e For breast cancer treatment protocols\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"7518\" data-end=\"7578\"\u003e\u003cem data-start=\"7518\" data-end=\"7578\"\u003eReference: U.S. FDA; ClinicalTrials.gov; PubMed; NCCN; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"7580\" data-end=\"7583\"\u003e\r\n\u003ch3 data-start=\"7585\" data-end=\"7605\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"7606\" data-end=\"8228\"\u003e\u003cstrong data-start=\"7606\" data-end=\"7629\"\u003eLetrozole (Femara®)\u003c\/strong\u003e is a well‑established aromatase inhibitor that plays a critical role in the management of hormone receptor‑positive breast cancer in postmenopausal women. By significantly reducing estrogen production, it helps to slow the growth of estrogen‑dependent tumors and improve patient outcomes. However, due to its potential impact on bone density, lipid profiles, and liver function, careful patient selection and monitoring are essential. Always consult your healthcare provider to ensure that letrozole is the appropriate treatment for your condition and to manage any potential risks or interactions.\u003c\/p\u003e\r\n\u003cp data-start=\"8230\" data-end=\"8448\"\u003e\u003cem data-start=\"8230\" data-end=\"8448\"\u003eDisclaimer: This guide is provided for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"2.5mg","offer_id":51736368873755,"sku":"Fempro-2.5mg","price":18.24,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/untitled_design_87.png?v=1770434898","url":"https:\/\/ezchemist.com\/products\/fempro","provider":"EZ Chemist","version":"1.0","type":"link"}